Showing results (11-20 of 48) with videos related to
Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|April 3, 2026
Increased CSF volume, altered brain development and emotional reactivity after postnatal Zika virus infection in infant rhesus macaquesNisarg Desai, Kaitlyn Love, Alex van Schoor, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2022
Rapid Detection and Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Variant in a Returning TravelerMary Elizabeth Sexton, Jesse J Waggoner, Ludy R Carmola, et al.Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.Nature Communications|June 12, 2021
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lungNanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, et al.Biorxiv : the Preprint Server for Biology|February 9, 2026
Mechanisms of disrupted neurodevelopment after Zika virus infection in infancyVenkata-Viswanadh Edara, Sienna Freeman, Maureen Sampson, et al.Cell Reports. Medicine|March 2, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.Structure (London, England : 1993)|May 11, 2023
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody responseAnamika Patel, Sanjeev Kumar, Lilin Lai, et al.Biorxiv : the Preprint Server for Biology|November 3, 2022
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody responseAnamika Patel, Sanjeev Kumar, Lilin Lai, et al.Biorxiv : the Preprint Server for Biology|April 1, 2021
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ SubjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.Cell Reports|July 8, 2021
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsMadeleine F Jennewein, Anna J MacCamy, Nicholas R Akins, et al.Pageof 5